/company/ | Subdomain | Company |
/company/about-us/ | Subdomain | About us |
/company/management/ | Subdomain | Management |
/company/supervisory-board/ | Subdomain | Supervisory Board |
/news-investors/ | Subdomain | News & Investors |
/news-investors/share-informat... | Subdomain | Share information |
/news-investors/share-informat... | Subdomain | Shareholders |
/news-investors/share-informat... | Subdomain | Analyst coverage |
/news-investors/share-informat... | Subdomain | Share Price |
/news-investors/ad-hoc-releases/ | Subdomain | News |
/category/press-releases/ | Subdomain | Press Releases |
/category/voting-rights/ | Subdomain | Voting Rights |
/category/other-mandatory-anno... | Subdomain | Other mandatory announcements |
/news-investors/financial-repo... | Subdomain | Financial Reports |
/news-investors/corporate-gove... | Subdomain | Corporate Governance |
/company/supervisory-board/ | Subdomain Textduplikat | Supervisory Board |
/category/directors-dealings/ | Subdomain | Directors’ Dealings |
/news-investors/corporate-gove... | Subdomain | Remuneration |
/news-investors/general-shareh... | Subdomain | General Shareholders’ Meeting |
/news-investors/financial-cale... | Subdomain | Financial Calendar |
/news-investors/convertible-bo... | Subdomain | Mandatory convertible bond 2021/2024 |
/news-investors/convertible-bo... | Subdomain | Mandatory convertible bond 2021/2027 |
/news-investors/disclaimer-cap... | Subdomain | Capital increase 2021 |
/news-investors/capital-increase/ | Subdomain | Capital increase 2019 |
/news-investors/contact/ | Subdomain | Contact |
/contact-form/ | Subdomain Textduplikat | Contact |
https://www.netgenerator.de/re... | Neues Fenster Extern Subdomain | Pharma Webdesign Berlin A-TITLE Die Webdesign-Agentur für die Pharma-Branche |
https://www.epigenomics.com/ | Subdomain | IMG-ALT Detecting cancer in blood A-TITLE Detecting cancer in blood |
https://www.epigenomics.com/ | Anchor | Menu A-TITLE Menu |
https://www.epigenomics.com/ | Subdomain | IMG-ALT Home A-TITLE Detecting cancer in blood |
https://www.epigenomics.com/ | Subdomain | en |
https://www.epigenomics.com/de/ | Subdomain | de |
/company/ | Subdomain Textduplikat | Company |
/company/about-us/ | Subdomain Textduplikat | About us |
/company/management/ | Subdomain Textduplikat | Management |
/company/supervisory-board/ | Subdomain Textduplikat | Supervisory Board |
/news-investors/ | Subdomain Textduplikat | News & Investors |
/news-investors/share-informat... | Subdomain Textduplikat | Share information |
/news-investors/share-informat... | Subdomain Textduplikat | Shareholders |
/news-investors/share-informat... | Subdomain Textduplikat | Analyst coverage |
/news-investors/share-informat... | Subdomain Textduplikat | Share Price |
/news-investors/ad-hoc-releases/ | Subdomain Textduplikat | News |
/category/press-releases/ | Subdomain Textduplikat | Press Releases |
/category/voting-rights/ | Subdomain Textduplikat | Voting Rights |
/category/other-mandatory-anno... | Subdomain Textduplikat | Other mandatory announcements |
/news-investors/financial-repo... | Subdomain Textduplikat | Financial Reports |
/news-investors/corporate-gove... | Subdomain Textduplikat | Corporate Governance |
/company/supervisory-board/ | Subdomain Textduplikat | Supervisory Board |
/category/directors-dealings/ | Subdomain Textduplikat | Directors’ Dealings |
/news-investors/corporate-gove... | Subdomain Textduplikat | Remuneration |
/news-investors/general-shareh... | Subdomain Textduplikat | General Shareholders’ Meeting |
/news-investors/financial-cale... | Subdomain Textduplikat | Financial Calendar |
/news-investors/convertible-bo... | Subdomain Textduplikat | Mandatory convertible bond 2021/2024 |
/news-investors/convertible-bo... | Subdomain Textduplikat | Mandatory convertible bond 2021/2027 |
/news-investors/disclaimer-cap... | Subdomain Textduplikat | Capital increase 2021 |
/news-investors/capital-increase/ | Subdomain Textduplikat | Capital increase 2019 |
/news-investors/contact/ | Subdomain Textduplikat | Contact |
/contact-form/ | Subdomain Textduplikat | Contact |
/epigenomics-ag-preliminary-an... | Subdomain | Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] |
/epigenomics-ag-preliminary-ha... | Subdomain | Epigenomics AG: Preliminary half-year results as at June 30, 2024 |
/epigenomics-ag-release-accord... | Subdomain | Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
/epigenomics-ag-executive-boar... | Subdomain | Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 |
/epigenomics-ag-executive-boar... | Subdomain Anchor | 0 comments |
/epigenomics-ag-release-accord... | Subdomain Textduplikat | Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
/epigenomics-ag-publishes-fina... | Subdomain | Epigenomics AG publishes financial results for fiscal year 2023 |
/epigenomics-ag-publishes-fina... | Subdomain Anchor Textduplikat | 0 comments |
https://www.epigenomics.com/ | Subdomain Textduplikat | Home |
/news-investors/contact/ | Subdomain Textduplikat | Contact |
/imprint/ | Subdomain | Imprint |
/imprint/data-protection-state... | Subdomain | Data Protection Statement |
/imprint/disclaimer/ | Subdomain | Disclaimer |
(Nice to have)